US Physical TherapyUSPH
About: US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Employees: 6,720
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
55% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 22
18% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 83
5% more funds holding
Funds holding: 242 [Q2] → 254 (+12) [Q3]
6.34% less ownership
Funds ownership: 108.65% [Q2] → 102.31% (-6.34%) [Q3]
14% less capital invested
Capital invested by funds: $1.51B [Q2] → $1.3B (-$209M) [Q3]
33% less funds holding in top 10
Funds holding in top 10: 3 [Q2] → 2 (-1) [Q3]
86% less call options, than puts
Call options by funds: $67K | Put options by funds: $491K
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
JP Morgan Calvin Sternick 0% 1-year accuracy 0 / 3 met price target | 20%upside $120 | Overweight Maintained | 3 Dec 2024 |
Barrington Research Michael Petusky 58% 1-year accuracy 25 / 43 met price target | 8%upside $108 | Outperform Maintained | 21 Nov 2024 |
Barrington Research Michael Petusky 58% 1-year accuracy 25 / 43 met price target | 8%upside $108 | Outperform Maintained | 7 Nov 2024 |
Barrington Research Michael Petusky 58% 1-year accuracy 25 / 43 met price target | 8%upside $108 | Outperform Maintained | 9 Oct 2024 |
B of A Securities Joanna Gajuk 100% 1-year accuracy 4 / 4 met price target | 10%downside $90 | Neutral Downgraded | 7 Oct 2024 |
Financial journalist opinion
Based on 6 articles about USPH published over the past 30 days